Table 2. Results from crude and adjusted analysis of change in fentanyl dose, ESAS QoL-score and infections (% days with antibiotics) compared to baseline in vitamin D treated and untreated patient after 1 month.
1 month (n = 39) | ||||
---|---|---|---|---|
Outcome | Mean change from baseline | Crude mean difference in change | Adjusted mean difference in change | |
Fentanyl | Treated | 6 μg/h | -46 μg/h (-78 –(-24) | -60 μg/h (-101– (-28)) |
Untreated | 52 μg/h | |||
ESAS | Treated | -1.1 | -1.4 (-2.6 –(-0.21)) | -1.4 (-2.90 –(-0.60)) |
Untreated | 0.2 | |||
Infections | Treated | -6% | -9% (-20%– 2%) | -6% (-17% –8%) |
Untreated | 3% |